Journal article
Total thrombin‐activatable fibrinolysis inhibitor (TAFI) antigen and pro‐TAFI in patients with haemophilia A
Abstract
Pro-thrombin-activatable fibrinolysis inhibitor (pro-TAFI), also known as TAFI, procarboxypeptidase U, or procarboxypeptidase B, is a relatively recently described plasma glycoprotein synthesized in the liver. It can be catalysed into its active form, TAFI (TAFIa, carboxypeptidase U or B) by a complex of thrombin/thrombomodulin. TAFI can potentially inhibit fibrinolysis by removing carboxyterminal lysine residues from partially degraded fibrin, …
Authors
Antovic J; Schulman S; Eelde A; Blombäck M
Journal
Haemophilia, Vol. 7, No. 6, pp. 557–560
Publisher
Wiley
Publication Date
November 12, 2001
DOI
10.1046/j.1365-2516.2001.00571.x
ISSN
1351-8216